Benzinga

Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Benzinga

Premium Services
Financial News
Financial News
Large Cap Stocks
Small-Cap Stocks
Insider Trades
Earnings
Technology
AI News
Personal Finance
ETF News
Crypto News
Dividend News
Latest Rumors
Latest Offerings News
Investment Ideas
Investment Ideas
Stock of the Day
Stock Whisper Index
Analyst Ratings
Analyst Color
Financial Advisors
Government Trades
Trading Ideas
Stock Screener
Markets
Markets
Premarket Movers
After Hours
Options
ETFs
Commodities
Prediction Markets
Private Markets
Bonds
Futures
Forex
Top Stocks
Top Stocks
Apple (AAPL)
Tesla (TSLA)
Amazon (AMZN)
Nvidia (NVDA)
Alphabet (GOOGL)
Meta Platforms (META)
Microsoft (MSFT)
StreetTracks Gold Shares (GLD)
IBIT Bitcoin Trust (IBIT)
Top Value Stocks
Top Momentum Stocks
Top Growth Stocks
Top Quality Stocks
Learn
Learn
Investing Guides
Personal Finance
Mortgages
Best Credit Cards
Best Dividend Stocks
Best Swing Trade Stocks

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Unusual Options Activity Calendar

Stock Split Calendar

Trade Ideas

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Options Profit Calculator

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Covered Call Calculator

Cash-Secured Put Calculator

Long Call Calculator

Long Put Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Compare Best Stocks

Best Momentum Stocks

Best Quality Stocks

Best Value Stocks

Best Growth Stocks

FibroBiologics Inc Stock News

FBLGNASDAQ

Trade with Public

Trade with Public

$1.04

-0.04-3.70%

Last update: May 20, 8:49 AM

OverviewNewsEarnings Analyst Ratings Insider Trades Short Interest Stock Report

Latest FibroBiologics Stock News | NASDAQ:FBLG | Benzinga

Get the latest news on FibroBiologics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on FibroBiologics performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, May 18, 2026

PRO
FibroBiologics Files New Provisional Patent A...
Benzinga Newsdesk

Monday, May 11, 2026

PRO
FibroBiologics Announces Strategic Expansion ...
Benzinga Newsdesk

Monday, May 04, 2026

PRO
FibroBiologics Reveals Preclinical Data Showi...
Benzinga Newsdesk
PRO
Maxim Group Downgrades FibroBiologics to Hold
Benzinga Newsdesk
EXCLUSIVE: FibroBiologics Targets 2026 Data Readout After Trial Progress For Diabetic Foot Ulcer Study
Vandana Singh
PRO
EXCLUSIVE: FibroBiologics Releases First Batc...
Benzinga Newsdesk

Friday, May 01, 2026

PRO
FibroBiologics Enters Into $6.15M Offering Of...
Benzinga Newsdesk

Thursday, April 30, 2026

PRO
FibroBiologics, Inc. - Common Stock Q1 EPS $(...
Benzinga Newsdesk

Monday, April 20, 2026

PRO
Nasdaq Confirms FibroBiologics Demonstrated C...
Benzinga Newsdesk

Thursday, April 16, 2026

PRO
HC Wainwright & Co. Maintains Buy on FibroBio...
Benzinga Newsdesk
PRO
FBS Global Receives Non-Compliance Notice Fro...
Benzinga Newsdesk

Wednesday, April 15, 2026

PRO
FibroBiologics Has Been Granted European Pate...
Benzinga Newsdesk

Friday, April 10, 2026

PRO
FibroBiologics Announces Preclinical Data Sup...
Benzinga Newsdesk

Wednesday, April 01, 2026

PRO
FibroBiologics shares are trading lower after...
Benzinga Newsdesk
Why nCino Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
PRO
Reported Earlier, FibroBiologics Prices $3M P...
Benzinga Newsdesk

Tuesday, March 31, 2026

PRO
FBLG stock has given up its prior gain. Fibro...
Benzinga Newsdesk
PRO
FibroBiologics shares are trading higher afte...
Benzinga Newsdesk
PRO
EXCLUSIVE: FibroBiologics Announces Successfu...
Benzinga Newsdesk
EXCLUSIVE: FibroBiologics Moves Forward With Human Trial For Diabetic Foot Ulcer Therapy
Vandana Singh

Monday, March 30, 2026

PRO
Trading Halt: Halt status updated at 8:55:00 ...
Benzinga Newsdesk

Friday, March 27, 2026

PRO
Trading Halt: Halted at 7:50:00 p.m. ET - Tra...
Benzinga Newsdesk

Thursday, March 26, 2026

PRO
D. Boral Capital Downgrades FibroBiologics to...
Benzinga Newsdesk

Wednesday, March 25, 2026

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
PRO
FibroBiologics shares are trading lower after...
Benzinga Newsdesk
PRO
FibroBiologics Approves 1-For-20 Reverse Stoc...
Benzinga Newsdesk

Tuesday, March 24, 2026

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights

Thursday, March 19, 2026

12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights

Thursday, March 12, 2026

PRO
FibroBiologics Expands Its Wound Care Platfor...
Benzinga Newsdesk

Thursday, March 05, 2026

PRO
FibroBiologics shares are trading higher afte...
Benzinga Newsdesk
PRO
FibroBiologics Completes Onboarding Of Clinic...
Benzinga Newsdesk

Monday, March 02, 2026

PRO
FibroBiologics Issued New U.S. Patent Entitle...
Benzinga Newsdesk

Thursday, February 26, 2026

PRO
HC Wainwright & Co. Maintains Buy on FibroBio...
Benzinga Newsdesk

Wednesday, February 25, 2026

PRO
D. Boral Capital Maintains Buy on FibroBiolog...
Benzinga Newsdesk

Tuesday, February 24, 2026

PRO
FibroBiologics, Inc. - Common Stock Q4 EPS $(...
Benzinga Newsdesk

Monday, February 23, 2026

PRO
FibroBiologics Receives Nasdaq Compliance Ext...
Benzinga Newsdesk

Thursday, February 05, 2026

PRO
FibroBiologics Issued Canadian IP Office Pate...
Benzinga Newsdesk
Why Align Technology Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Avi Kapoor

Friday, January 23, 2026

12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights

Tuesday, January 06, 2026

PRO
D. Boral Capital Maintains Buy on FibroBiolog...
Benzinga Newsdesk

Monday, January 05, 2026

PRO
FibroBiologics Reports Preclinical Results Fo...
Benzinga Newsdesk

Friday, January 02, 2026

PRO
HC Wainwright & Co. Reiterates Buy on FibroBi...
Benzinga Newsdesk

Wednesday, December 31, 2025

PRO
FBLG stock has given up its prior gain. Fibro...
Benzinga Newsdesk
PRO
FibroBiologics shares are trading higher afte...
Benzinga Newsdesk
PRO
FibroBiologics Announces The Filing Of A Phas...
Benzinga Newsdesk

Friday, December 19, 2025

12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights

Wednesday, December 17, 2025

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights

Tuesday, December 16, 2025

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights

Monday, December 15, 2025

PRO
FibroBiologics shares are trading lower after...
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investor Events
Pre-market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2026 Benzinga | All Rights Reserved